InvestorsHub Logo
Followers 4054
Posts 151292
Boards Moderated 4
Alias Born 08/05/2009

Re: Letsgosilver post# 17

Wednesday, 05/20/2020 12:23:20 PM

Wednesday, May 20, 2020 12:23:20 PM

Post# of 174
This is the email I got back from ACER after pleading for a PR (lol)


looks like the info is not new, and already public info, so now I get why the debt holders sold it off from 7.67




-----Original Message-----
From: Investors <investors@acertx.com>
To: Investors <investors@acertx.com>; hans@lifesciadvisors.com <hans@lifesciadvisors.com>
Sent: Wed, May 20, 2020 9:05 am
Subject: RE: Formal Press Release **NEEDED***

Jeremiah:



Thank you for your interest in Acer Therapeutics. The data we referenced yesterday and this morning are from publications already posted on our website and cited in our current investor presentation, which is also posted on our website, and follows last week’s press releases. The emetine data included in the publications on our website and the subject of our tweets this week are based on published in vitro data.

Please see the following links to our:



Emetine Press Release 5/11/20

https://www.acertx.com/2020/05/11/acer-therapeutics-to-develop-emetine-as-potential-covid-19-treatment-in-collaboration-with-national-center-for-advancing-translational-sciences-one-of-the-national-institutes-of-health/



Q1 Earnings Release 5/14/20

https://www.acertx.com/2020/05/14/acer-therapeutics-reports-first-quarter-2020-financial-results-and-provides-corporate-update/

Always consult an Investment Professional, my posts are my own opinions, and not for investing decisions

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.